Nitrofurantoin polyneuropathy.
D000284:Administration, Oral; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D006801:Humans; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000134:cerebrospinal fluid / Q000139:chemically induced*; D011379:Prognosis; D013129:Spinal Puncture; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D002556:Cerebrospinal Fluid Proteins; D009582:Nitrofurantoin